OWENS & MINOR INC/VA/ - Quarter Report: 2016 March (Form 10-Q)

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________________________________

FORM 10-Q

________________________________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-9810

_______________________________________________________

Owens & Minor, Inc.

(Exact name of Registrant as specified in its charter)

_______________________________________________________



Virginia	54-1701843
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

9120 Lockwood Boulevard, Mechanicsville, Virginia	23116
(Address of principal executive offices)	(Zip Code)

Post Office Box 27626, Richmond, Virginia	23261-7626
(Mailing address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (804) 723-7000

_________________________________________________________

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “larger accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of Owens & Minor, Inc.’s common stock outstanding as of April 29, 2016, was 62,794,080 shares.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Index



Part I. Financial Information		Page

Item 1.	Financial Statements	3
	Consolidated Statements of Income—Three Months Ended March 31, 2016 and 2015	3
	Consolidated Statements of Comprehensive Income (Loss) —Three Months Ended March 31, 2016 and 2015	4
	Consolidated Balance Sheets—March 31, 2016 and December 31, 2015	5
	Consolidated Statements of Cash Flows—Three Months Ended March 31, 2016 and 2015	6
	Consolidated Statements of Changes in Equity—Three Months Ended March 31, 2016 and 2015	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27
Item 4.	Controls and Procedures	27
Part II. Other Information
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities	28
Item 6.	Exhibits	30

Table of Contents

Part I. Financial Information

Item 1. Financial Statements

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Income

(unaudited)



	Three Months Ended March 31,
(in thousands, except per share data)	2016			2015
Net revenue	$	2,455,793		$	2,391,196
Cost of goods sold	2,159,157			2,093,595
Gross margin	296,636			297,601
Distribution, selling and administrative expenses	242,725			249,694
Acquisition-related and exit and realignment charges	10,483			9,916
Other operating income, net	(1,542		)	(2,984		)
Operating earnings	44,970			40,975
Interest expense, net	6,790			6,880
Income before income taxes	38,180			34,095
Income tax provision	14,045			15,155
Net income	$	24,135		$	18,940
Net income per common share:
Basic	$	0.39		$	0.30
Diluted	$	0.39		$	0.30
Cash dividends per common share	$	0.255		$	0.2525

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)



	Three Months Ended March 31,
(in thousands)	2016		2015
Net income	$	24,135	$	18,940
Other comprehensive income (loss), net of tax:
Currency translation adjustments (net of income tax of $0 in 2016 and 2015)	8,162		(27,941		)
Change in unrecognized net periodic pension costs (net of income tax of $171 in 2016 and $143 in 2015)	238		258
Other (net of income tax of $0 in 2016 and 2015)	19		38
Total other comprehensive income (loss), net of tax	8,419		(27,645		)
Comprehensive income (loss)	$	32,554	$	(8,705	)

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Balance Sheets

(unaudited)



	March 31,			December 31,
(in thousands, except per share data)	2016			2015
Assets
Current assets
Cash and cash equivalents	$	190,323		$	161,020
Accounts and notes receivable, net of allowances of $13,234 and $13,177	615,750			587,935
Merchandise inventories	925,714			940,775
Other current assets	269,698			284,970
Total current assets	2,001,485			1,974,700
Property and equipment, net of accumulated depreciation of $197,285 and $189,105	208,033			208,930
Goodwill, net	420,071			419,619
Intangible assets, net	93,347			95,250
Other assets, net	73,905			75,277
Total assets	$	2,796,841		$	2,773,776
Liabilities and equity
Current liabilities
Accounts payable	$	758,585		$	710,609
Accrued payroll and related liabilities	30,327			45,907
Other current liabilities	278,026			307,073
Total current liabilities	1,066,938			1,063,589
Long-term debt, excluding current portion	567,711			568,495
Deferred income taxes	93,275			86,326
Other liabilities	63,996			62,776
Total liabilities	1,791,920			1,781,186
Commitments and contingencies
Equity
Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 62,802 shares and 62,803 shares	125,604			125,606
Paid-in capital	213,016			211,943
Retained earnings	709,707			706,866
Accumulated other comprehensive income	(43,406		)	(51,825		)
Total equity	1,004,921			992,590
Total liabilities and equity	$	2,796,841		$	2,773,776

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(unaudited)



	Three Months Ended March 31,
(in thousands)	2016			2015
Operating activities:
Net income	$	24,135		$	18,940
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	14,218			19,123
Share-based compensation expense	2,603			2,597
Provision for losses on accounts and notes receivable	115			220
Deferred income tax expense	6,907			510
Changes in operating assets and liabilities:
Accounts and notes receivable	(26,815		)	27,356
Merchandise inventories	15,178			(3,888		)
Accounts payable	46,751			88,944
Net change in other assets and liabilities	(38,100		)	13,580
Other, net	(97		)	1,321
Cash provided by operating activities	44,895			168,703
Investing activities:
Additions to property and equipment	(5,283		)	(7,619		)
Additions to computer software and intangible assets	(1,777		)	(3,947		)
Proceeds from sale of property and equipment	4,599			50
Cash used for investing activities	(2,461		)	(11,516		)
Financing activities:
Change in bank overdraft	8,359			1,179
Repayment of revolving credit facility	—			(33,700		)
Cash dividends paid	(16,029		)	(15,934		)
Repurchases of common stock	(5,630		)	—
Excess tax benefits related to share-based compensation	250			240
Proceeds from exercise of stock options	—			125
Other, net	(3,016		)	(2,324		)
Cash used for financing activities	(16,066		)	(50,414		)
Effect of exchange rate changes on cash and cash equivalents	2,935			(4,489		)
Net increase in cash and cash equivalents	29,303			102,284
Cash and cash equivalents at beginning of period	161,020			56,772
Cash and cash equivalents at end of period	$	190,323		$	159,056
Supplemental disclosure of cash flow information:
Income taxes paid, net	$	20,028		$	4,509
Interest paid	$	6,226		$	5,924

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Changes in Equity

(unaudited)



	Owens & Minor, Inc. Shareholders’ Equity
(in thousands, except per share data)	Common Shares Outstanding		Common Stock ($ 2 par value )			Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Equity
Balance December 31, 2014	63,070		$	126,140		$	202,934	$	685,765		$	(24,001	)	$	990,838
Net income								18,940						18,940
Other comprehensive income (loss)											(27,645		)	(27,645		)
Dividends declared ($0.2525 per share)								(15,892		)				(15,892		)
Share-based compensation expense, exercises and other	32		65			1,967								2,032
Balance March 31, 2015	63,102		$	126,205		$	204,901	$	688,813		$	(51,646	)	$	968,273

Balance December 31, 2015	62,803		$	125,606		$	211,943	$	706,866		$	(51,825	)	$	992,590
Net income								24,135						24,135
Other comprehensive income (loss)											8,419			8,419
Dividends declared ($0.255 per share)								(15,989		)				(15,989		)
Shares repurchased and retired	(163	)	(325		)			(5,305		)				(5,630		)
Share-based compensation expense, exercises and other	162		323			1,073								1,396
Balance March 31, 2016	62,802		$	125,604		$	213,016	$	709,707		$	(43,406	)	$	1,004,921

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(unaudited)

(in thousands, unless otherwise indicated)

Note 1—Basis of Presentation and Use of Estimates

Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, or our) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.

Recently, we have made certain changes to the leadership team, organizational structure, budgeting and financial reporting processes which drive changes to segment reporting. These changes align our operations into three distinct business units: Domestic, International and Clinical & Procedural Solutions (CPS). Domestic is our U.S.distribution, logistics and value-added services business, while International is our European distribution, logistics and value-added services business. CPS provides product-related solutions, including surgical and procedural kitting and sourcing. Beginning with the quarter ended March 31, 2016, we now report financial results using this three segment structure and have recast prior year segment results on the same basis.

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation. Depreciation and amortization, previously reported as a separate financial statement line item in the consolidated statements of income is now included in distribution, selling and administrative expenses for all periods presented.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.

Note 2—Fair Value

The carrying amounts of cash and cash equivalents, accounts receivable, financing receivables, accounts payable and financing payables included in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. The fair value of long-term debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings and average remaining maturities (Level 2). We determine the fair value of our derivatives based on estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies. See Note 7 for the fair value of long-term debt and Note 8 for the fair value of derivatives.

Note 3—Financing Receivables and Payables

At March 31, 2016 and December 31, 2015, we had financing receivables of $165.5 million and $198.5 million and related payables of $105.4 million and $148.5 million outstanding under our order-to-cash program and product financing arrangements, which were included in other current assets and other current liabilities, respectively, in the consolidated balance sheets.

Note 4—Goodwill and Intangible Assets

In connection with our new three segment structure, goodwill has been reallocated based on the relative fair value of the underlying reporting units. We performed an interim impairment analysis as a result of this change and noted no impairment. The following table summarizes the reallocated goodwill balances by segment and the changes in the carrying amount of goodwill through March 31, 2016:



	Domestic		International			CPS		Consolidated
Carrying amount of goodwill, December 31, 2015	$	180,006	$	23,426		$	216,187	$	419,619
Currency translation adjustments	—		(280		)	732		452
Carrying amount of goodwill, March 31, 2016	$	180,006	$	23,146		$	216,919	$	420,071

Table of Contents

Intangible assets at March 31, 2016, and December 31, 2015, were as follows:



	March 31, 2016						December 31, 2015
	Customer Relationships			Other Intangibles			Customer Relationships			Other Intangibles

Gross intangible assets	$	122,467		$	4,733		$	121,888		$	4,621
Accumulated amortization	(32,419		)	(1,434		)	(29,872		)	(1,387		)
Net intangible assets	$	90,048		$	3,299		$	92,016		$	3,234

At March 31, 2016, $13.2 million in net intangible assets were held in the Domestic segment, $14.4 million were held in the International segment and $65.8 million were held in the CPS segment. Amortization expense for intangible assets was $2.2 million and $2.4 million for the three months ended March 31, 2016 and 2015.

Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $7.8 million for the remainder of 2016, $9.9 million for 2017, $9.3 million for 2018, $9.2 million for 2019, $9.0 million for 2020 and $8.6 million for 2021.

Note 5—Exit and Realignment Costs

We periodically incur exit and realignment and other charges associated with optimizing our operations which include the closure and consolidation of certain distribution and logistics centers, administrative offices and warehouses in the United States and Europe. These charges also include costs associated with our strategic organizational realignment which include management changes, certain professional fees, and costs to streamline administrative functions and processes.

Exit and realignment charges by segment for the three months ended March 31, 2016 and 2015 were as follows:



	Three Months Ended March 31,
	2016		2015
Domestic segment	$	8,074	$	2,639
International segment	1,700		4,672
CPS segment	1,108		—
Total exit and realignment charges	$	10,882	$	7,311

For the quarter ended March 31, 2016, $9.9 million in charges were associated with our voluntary employee separation program and other severance activities. The following table summarizes the activity related to exit and realignment cost accruals through March 31, 2016 and 2015:



	Lease Obligations			Severance and Other			Total
Accrued exit and realignment costs, December 31, 2015	$	486		$	1,840		$	2,326
Provision for exit and realignment activities	—			9,895			9,895
Cash payments, net of sublease income	(486		)	(1,287		)	(1,773		)
Accrued exit and realignment costs, March 31, 2016	$	—		$	10,448		$	10,448


Accrued exit and realignment costs, December 31, 2014	$	3,575		$	2,887		$	6,462
Provision for exit and realignment activities	256			142			398
Cash payments, net of sublease income	(385		)	(873		)	(1,258		)
Accrued exit and realignment costs, March 31, 2015	$	3,446		$	2,156		$	5,602

In addition to the exit and realignment accruals in the preceding table, we also incurred $1.0 million of costs that were expensed as incurred for the quarter ended March 31, 2016, including $0.5 million in information systems costs, $0.4 million in consulting costs and $0.1 million in other costs.

Table of Contents

We incurred $6.9 million of costs that were expensed as incurred for the quarter ended March 31, 2015 including $3.0 million in accelerated amortization of an information system that has been replaced, $1.8 million in facility costs, $1.3 million in labor costs, $0.3 million in information systems costs and $0.5 million in other costs.

Note 6—Retirement Plans

We have a noncontributory, unfunded retirement plan for certain officers and other key employees in the United States. Certain of our foreign subsidiaries also have defined benefit pension plans covering substantially all of their respective employees.

The components of net periodic benefit cost, which are included in distribution, selling and administrative expenses, for the three months ended March 31, 2016 and 2015, were as follows:



	Three Months Ended March 31,
	2016		2015
Service cost	$	23	$	33
Interest cost	505		464
Recognized net actuarial loss	409		401
Net periodic benefit cost	$	937	$	898

Certain of our foreign subsidiaries have health and welfare plans covering substantially all of their respective employees. Our expense for these plans totaled $0.4 million and $0.5 million for the three months ended March 31, 2016 and 2015.

Note 7—Debt

We have $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”), with interest payable semi-annually. The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal with an effective yield of 4.422%. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points. As of March 31, 2016 and December 31, 2015, the estimated fair value of the 2021 Notes was $277.4 million and $273.7 million and the estimated fair value of the 2024 Notes was $277.0 million and $272.8 million, respectively.

We have a Credit Agreement with a $450 million borrowing capacity which extends through September 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. Based on our leverage ratio at March 31, 2016, the interest rate under the credit facility is LIBOR plus 1.375%.

At March 31, 2016, we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of March 31, 2016 and 2015, which supports our facilities leased in Europe.

The Amended Credit Agreement and senior notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at March 31, 2016.

Note 8—Derivatives

When deemed appropriate, we use derivatives, primarily forward contracts, as a risk management tool to mitigate the potential impact of foreign currency exchange risk. The total notional values of our foreign currency derivatives was $0.9 million at March 31, 2016 and $2.0 million as of December 31, 2015. We do not currently have any derivatives designated as hedging instruments and all gains and losses resulting from changes in the fair value of derivative instruments are immediately recognized into earnings. At March 31, 2016 and December 31, 2015 the fair value of our foreign currency contracts included in other assets on the consolidated balance sheet was $0.1 million and $0.4 million. The impact from changes in the fair value

Table of Contents

of these foreign currency derivatives included in other operating income, net was a $0.3 million loss for the first quarter of 2016 and a $0.8 million gain for the first quarter of 2015. We consider the risk of counterparty default to be minimal.

Note 9—Income Taxes

The effective tax rate was 36.8% for the three months ended March 31, 2016, compared to 44.4% in the same quarter of 2015. The change in rate resulted from a higher percentage of the company's pretax income earned in lower tax rate jurisdictions compared to prior year and the deductibility of certain prior year acquisition-related charges for income tax purposes. The liability for unrecognized tax benefits was $8.5 million at March 31, 2016 and $7.7 million at December 31, 2015. Included in the liability at March 31, 2016 were $4.1 million of tax positions for which ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.

Note 10—Net Income per Common Share

The following summarizes the calculation of net income per common share attributable to common shareholders for the three months ended March 31, 2016 and 2015.



	Three Months Ended March 31,
(in thousands, except per share data)	2016			2015
Numerator:
Net income	$	24,135		$	18,940
Less: income allocated to unvested restricted shares	(276		)	(161		)
Net income attributable to common shareholders - basic	23,859			18,779
Add: undistributed income attributable to unvested restricted shares - basic	57			18
Less: undistributed income attributable to unvested restricted shares - diluted	(57		)	(18		)
Net income attributable to common shareholders - diluted	$	23,859		$	18,779
Denominator:
Weighted average shares outstanding - basic	61,696			62,264
Dilutive shares - stock options	—			2
Weighted average shares outstanding - diluted	61,696			62,266
Net income per share attributable to common shareholders:
Basic	$	0.39		$	0.30
Diluted	$	0.39		$	0.30

Note 11—Shareholders’ Equity

Our Board of Directors has authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plans and return capital to shareholders. The program may be suspended or discontinued at any time. During the three months ended March 31, 2016, we repurchased in open-market transactions and retired approximately 0.2 million shares of our common stock for an aggregate of $5.6 million, or an average price per share of $34.61. As of March 31, 2016, we have approximately $64.4 million remaining under the repurchase program. We have elected to allocate any excess of share repurchase price over par value to retained earnings.

Table of Contents

Note 12—Accumulated Other Comprehensive Income

The following table shows the changes in accumulated other comprehensive income (loss) by component for the three months ended March 31, 2016 and 2015:



	Retirement Plans			Currency Translation Adjustments			Other			Total
Accumulated other comprehensive income (loss), December 31, 2015	$	(10,482	)	$	(41,228	)	$	(115	)	$	(51,825	)
Other comprehensive income (loss) before reclassifications	—			8,162			—			8,162
Income tax	—			—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—			8,162			—			8,162
Amounts reclassified from accumulated other comprehensive income (loss)	409			—			19			428
Income tax	(171		)	—			—			(171		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	238			—			19			257
Other comprehensive income (loss)	238			8,162			19			8,419
Accumulated other comprehensive income (loss), March 31, 2016	$	(10,244	)	$	(33,066	)	$	(96	)	$	(43,406	)



	Retirement Plans			Currency Translation Adjustments			Other			Total
Accumulated other comprehensive income (loss), December 31, 2014	$	(10,323	)	$	(13,647	)	$	(31	)	$	(24,001	)
Other comprehensive income (loss) before reclassifications	—			(27,941		)	38			(27,903		)
Income tax	—			—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—			(27,941		)	38			(27,903		)
Amounts reclassified from accumulated other comprehensive income (loss)	401			—			—			401
Income tax	(143		)	—			—			(143		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	258			—			—			258
Other comprehensive income (loss)	258			(27,941		)	38			(27,645		)
Accumulated other comprehensive income (loss), March 31, 2015	$	(10,065	)	$	(41,588	)	$	7		$	(51,646	)

We include amounts reclassified out of accumulated other comprehensive income related to defined benefit pension plans as a component of net periodic pension cost recorded in distribution, selling and administrative expenses. For the three months ended March 31, 2016 and 2015, we reclassified $0.4 million of actuarial net losses.

Note 13—Segment Information

We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under three segments: Domestic, International and Clinical & Procedural Solutions (CPS). The Domestic segment includes our United States distribution, logistics and value-added services business. The International segment consists of our European distribution, logistics and value-added services business. CPS provides product-related solutions, including surgical and procedural kitting and sourcing.

Table of Contents

We evaluate the performance of our segments based on their operating earnings excluding acquisition-related and exit and realignment charges, certain purchase price fair value adjustments, and other substantive items that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis. Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading or not meaningful. We believe all inter-segment sales are at prices that approximate market.

The following tables present financial information by segment:



	Three Months Ended March 31,
	2016			2015
Net revenue:
Segment net revenue
Domestic	$	2,321,708		$	2,249,705
International	83,551			95,511
CPS	141,353			129,645
Total segment net revenue	2,546,612			2,474,861
Inter-segment revenue
CPS	(90,819		)	(83,665		)
Total inter-segment revenue	(90,819		)	(83,665		)
Consolidated net revenue	$	2,455,793		$	2,391,196

Operating earnings (loss):
Domestic	$	41,718		$	38,106
International	1,128			(337		)
CPS	13,271			13,182
Inter-segment eliminations	(664		)	(60		)
Acquisition-related and exit and realignment charges ⁽¹⁾	(10,483		)	(9,916		)
Consolidated operating earnings	$	44,970		$	40,975

Depreciation and amortization:
Domestic	$	7,542		$	9,083
International	4,450			4,895
CPS	2,226			2,191
Consolidated depreciation and amortization	$	14,218		$	16,169

Capital expenditures:
Domestic	$	4,543		$	8,009
International	1,970			2,915
CPS	547			642
Consolidated capital expenditures	$	7,060		$	11,566

⁽¹⁾The first quarter of 2015 included $3.0 million in accelerated amortization related to an information system that was replaced in the International segment.

Table of Contents



	March 31, 2016		December 31, 2015
Total assets:
Domestic	$	1,742,187	$	1,728,345
International	448,969		464,003
CPS	415,362		420,408
Segment assets	2,606,518		2,612,756
Cash and cash equivalents	190,323		161,020
Consolidated total assets	$	2,796,841	$	2,773,776

Note 14—Condensed Consolidating Financial Information

The following tables present condensed consolidating financial information for: Owens & Minor, Inc. (O&M); the guarantors of Owens & Minor, Inc.’s 2021 Notes and 2024 Notes, on a combined basis; and the non-guarantor subsidiaries of the 2021 Notes and 2024 Notes, on a combined basis. The guarantor subsidiaries are 100% owned by Owens & Minor, Inc. Separate financial statements of the guarantor subsidiaries are not presented because the guarantees by our guarantor subsidiaries are full and unconditional, as well as joint and several, and we believe the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries.



Three Months Ended March 31, 2016	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Three Months Ended March 31, 2016	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,321,708		$	172,101		$	(38,016	)	$	2,455,793
Cost of goods sold	—			2,105,264			92,075			(38,182		)	2,159,157
Gross margin	—			216,444			80,026			166			296,636
Distribution, selling and administrative expenses	534			169,310			72,881			—			242,725
Acquisition-related and exit and realignment charges	—			8,402			2,081			—			10,483
Other operating income, net	—			(1,384		)	(158		)	—			(1,542		)
Operating earnings (loss)	(534		)	40,116			5,222			166			44,970
Interest expense (income), net	6,840			(629		)	579			—			6,790
Income (loss) before income taxes	(7,374		)	40,745			4,643			166			38,180
Income tax (benefit) provision	—			11,547			2,498			—			14,045
Equity in earnings of subsidiaries	31,509			—			—			(31,509		)	—
Net income (loss)	24,135			29,198			2,145			(31,343		)	24,135
Other comprehensive income (loss)	8,419			257			8,162			(8,419		)	8,419
Comprehensive income (loss)	$	32,554		$	29,455		$	10,307		$	(39,762	)	$	32,554

Table of Contents



Three Months Ended March 31, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,250,704		$	180,361		$	(39,869	)	$	2,391,196
Cost of goods sold	—			2,034,032			99,818			(40,255		)	2,093,595
Gross margin	—			216,672			80,543			386			297,601
Distribution, selling and administrative expenses	39			169,680			79,975			—			249,694
Acquisition-related and exit and realignment charges	—			3,577			6,339			—			9,916
Other operating income, net	—			(976		)	(2,008		)	—			(2,984		)
Operating earnings (loss)	(39		)	44,391			(3,763		)	386			40,975
Interest expense (income), net	5,947			764			169			—			6,880
Income (loss) before income taxes	(5,986		)	43,627			(3,932		)	386			34,095
Income tax (benefit) provision	(773		)	15,231			697			—			15,155
Equity in earnings of subsidiaries	24,153			—			—			(24,153		)	—
Net income (loss)	18,940			28,396			(4,629		)	(23,767		)	18,940
Other comprehensive income (loss)	(27,645		)	504			(28,149		)	27,645			(27,645		)
Comprehensive income (loss)	$	(8,705	)	$	28,900		$	(32,778	)	$	3,878		$	(8,705	)

Table of Contents



March 31, 2016	Owens & Minor, Inc.			Guarantor Subsidiaries			Non- guarantor Subsidiaries			Eliminations			Consolidated
March 31, 2016	Owens & Minor, Inc.			Guarantor Subsidiaries			Non- guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	132,179		$	9,514		$	48,630		$	—		$	190,323
Accounts and notes receivable, net	—			530,547			94,335			(9,132		)	615,750
Merchandise inventories	—			872,376			55,558			(2,220		)	925,714
Other current assets	7			85,246			184,445			—			269,698
Total current assets	132,186			1,497,683			382,968			(11,352		)	2,001,485
Property and equipment, net	—			102,937			105,096			—			208,033
Goodwill, net	—			180,006			240,065			—			420,071
Intangible assets, net	—			13,213			80,134			—			93,347
Due from O&M and subsidiaries	—			564,018			—			(564,018		)	—
Advances to and investment in consolidated subsidiaries	1,991,311			—			—			(1,991,311		)	—
Other assets, net	—			56,005			17,900			—			73,905
Total assets	$	2,123,497		$	2,413,862		$	826,163		$	(2,566,681	)	$	2,796,841
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	707,358		$	60,359		$	(9,132	)	$	758,585
Accrued payroll and related liabilities	—			18,287			12,040			—			30,327
Other accrued liabilities	7,488			117,778			152,760			—			278,026
Total current liabilities	7,488			843,423			225,159			(9,132		)	1,066,938
Long-term debt, excluding current portion	544,197			4,121			19,393			—			567,711
Due to O&M and subsidiaries	566,891			—			59,213			(626,104		)	—
Intercompany debt	—			138,890			—			(138,890		)	—
Deferred income taxes	—			71,484			21,791			—			93,275
Other liabilities	—			57,586			6,410			—			63,996
Total liabilities	1,118,576			1,115,504			331,966			(774,126		)	1,791,920
Equity
Common stock	125,604			—			—			—			125,604
Paid-in capital	213,016			174,612			583,867			(758,479		)	213,016
Retained earnings (deficit)	709,707			1,133,985			(56,503		)	(1,077,482		)	709,707
Accumulated other comprehensive income (loss)	(43,406		)	(10,239		)	(33,167		)	43,406			(43,406		)
Total equity	1,004,921			1,298,358			494,197			(1,792,555		)	1,004,921
Total liabilities and equity	$	2,123,497		$	2,413,862		$	826,163		$	(2,566,681	)	$	2,796,841

Table of Contents



December 31, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	103,284		$	5,614		$	52,122		$	—		$	161,020
Accounts and notes receivable, net	—			507,673			89,895			(9,633		)	587,935
Merchandise inventories	—			883,232			59,930			(2,387		)	940,775
Other current assets	104			72,683			212,183			—			284,970
Total current assets	103,388			1,469,202			414,130			(12,020		)	1,974,700
Property and equipment, net	—			103,219			105,711			—			208,930
Goodwill, net	—			180,006			239,613			—			419,619
Intangible assets, net	—			13,731			81,519			—			95,250
Due from O&M and subsidiaries	—			518,473			—			(518,473		)	—
Advances to and investments in consolidated subsidiaries	1,967,176			—			—			(1,967,176		)	—
Other assets, net	—			57,409			17,868			—			75,277
Total assets	$	2,070,564		$	2,342,040		$	858,841		$	(2,497,669	)	$	2,773,776
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	662,909		$	56,073		$	(8,373	)	$	710,609
Accrued payroll and related liabilities	—			32,094			13,813			—			45,907
Other current liabilities	6,924			109,137			191,012			—			307,073
Total current liabilities	6,924			804,140			260,898			(8,373		)	1,063,589
Long-term debt, excluding current portion	543,982			4,527			19,986			—			568,495
Due to O&M and subsidiaries	527,068			—			70,089			(597,157		)	—
Intercompany debt	—			138,890			—			(138,890		)	—
Deferred income taxes	—			67,562			18,764			—			86,326
Other liabilities	—			57,573			5,203			—			62,776
Total liabilities	1,077,974			1,072,692			374,940			(744,420		)	1,781,186
Equity
Common stock	125,606			—			—			—			125,606
Paid-in capital	211,943			174,612			583,873			(758,485		)	211,943
Retained earnings (deficit)	706,866			1,104,787			(58,648		)	(1,046,139		)	706,866
Accumulated other comprehensive income (loss)	(51,825		)	(10,051		)	(41,324		)	51,375			(51,825		)
Total equity	992,590			1,269,348			483,901			(1,753,249		)	992,590
Total liabilities and equity	$	2,070,564		$	2,342,040		$	858,841		$	(2,497,669	)	$	2,773,776

Table of Contents



Three Months Ended March 31, 2016	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated

Statements of Cash Flows
Operating activities:
Net income (loss)	$	24,135		$	29,198		$	2,145		$	(31,343	)	$	24,135
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	(31,509		)	—			—			31,509			—
Depreciation and amortization	—			7,569			6,649			—			14,218
Share-based compensation expense	—			2,603			—			—			2,603
Provision for losses on accounts and notes receivable	—			128			(13		)	—			115
Deferred income tax expense (benefit)	—			3,922			2,985			—			6,907
Changes in operating assets and liabilities:
Accounts and notes receivable	—			(23,002		)	(4,569		)	756			(26,815		)
Merchandise inventories	—			10,856			4,490			(168		)	15,178
Accounts payable	—			44,449			3,056			(754		)	46,751
Net change in other assets and liabilities	661			(15,780		)	(22,981		)	—			(38,100		)
Other, net	214			123			(434		)	—			(97		)
Cash provided by (used for) operating activities	(6,499		)	60,066			(8,672		)	—			44,895
Investing activities:
Additions to property and equipment	—			(3,928		)	(1,355		)	—			(5,283		)
Additions to computer software and intangible assets	—			(615		)	(1,162		)	—			(1,777		)
Proceeds from the sale of property and equipment	—			3			4,596			—			4,599
Cash provided by (used for) investing activities	—			(4,540		)	2,079			—			(2,461		)
Financing activities:
Change in bank overdraft	—			—			8,359			—			8,359
Change in intercompany advances	58,435			(51,009		)	(7,426		)	—			—
Cash dividends paid	(16,029		)	—			—			—			(16,029		)
Repurchases of common stock	(5,630		)	—			—			—			(5,630		)
Excess tax benefits related to share-based compensation	250			—			—			—			250
Other, net	(1,632		)	(617		)	(767		)	—			(3,016		)
Cash provided by (used for) financing activities	35,394			(51,626		)	166			—			(16,066		)
Effect of exchange rate changes on cash and cash equivalents	—			—			2,935			—			2,935
Net increase (decrease) in cash and cash equivalents	28,895			3,900			(3,492		)	—			29,303
Cash and cash equivalents at beginning of period	103,284			5,614			52,122			—			161,020
Cash and cash equivalents at end of period	$	132,179		$	9,514		$	48,630		$	—		$	190,323

Table of Contents



Three Months Ended March 31, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated

Statements of Cash Flows
Operating activities:
Net income (loss)	$	18,940		$	28,396		$	(4,629	)	$	(23,767	)	$	18,940
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	(24,153		)	—			—			24,153			—
Depreciation and amortization	—			9,105			10,018			—			19,123
Share-based compensation expense	—			2,597			—			—			2,597
Provision for losses on accounts and notes receivable	—			(36		)	256			—			220
Deferred income tax expense (benefit)	—			(373		)	883			—			510
Changes in operating assets and liabilities:
Accounts and notes receivable	—			26,519			(5,561		)	6,398			27,356
Merchandise inventories	—			(2,348		)	(3,928		)	2,388			(3,888		)
Accounts payable	—			92,359			3,424			(6,839		)	88,944
Net change in other assets and liabilities	541			16,418			(1,046		)	(2,333		)	13,580
Other, net	209			636			476						1,321
Cash provided by (used for) operating activities	(4,463		)	173,273			(107		)	—			168,703
Investing activities:
Additions to property and equipment	—			(6,552		)	(1,067		)	—			(7,619		)
Additions to computer software and intangible assets	—			(1,457		)	(2,490		)	—			(3,947		)
Proceeds from the sale of property and equipment	—			50			—			—			50
Cash provided by (used for) investing activities	—			(7,959		)	(3,557		)	—			(11,516		)
Financing activities:
Change in bank overdraft	—			—			1,179			—			1,179
Change in intercompany advances	114,499			(124,681		)	10,182			—			—
Repayment of revolving credit facility	—			(33,700		)	—			—			(33,700		)
Cash dividends paid	(15,934		)	—			—			—			(15,934		)
Excess tax benefits related to share-based compensation	240			—			—			—			240
Proceeds from exercise of stock options	125			—			—			—			125
Other, net	(867		)	(710		)	(747		)	—			(2,324		)
Cash provided by (used for) financing activities	98,063			(159,091		)	10,614			—			(50,414		)
Effect of exchange rate changes on cash and cash equivalents	—			—			(4,489		)	—			(4,489		)
Net increase (decrease) in cash and cash equivalents	93,600			6,223			2,461			—			102,284
Cash and cash equivalents at beginning of period	22,013			3,912			30,847			—			56,772
Cash and cash equivalents at end of period	$	115,613		$	10,135		$	33,308		$	—		$	159,056

Table of Contents

Note 15—Recent Accounting Pronouncements

On January 1, 2016, we adopted ASU 2015-03, Interest-Imputation of Interest: Simplifying the Presentation of Debt Issuance Costs, which requires that our $3.9 million in debt issuance costs at March 31, 2016 related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. As a result of this adoption, we have also presented $4.1 million in debt issuance costs from our December 31, 2015 balance sheet in a manner that conforms to the new presentation. The adoption of this standard did not affect our results of operations or cash flows in either the current or prior interim or annual periods.

In February 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-02, Leases. The new standard establishes a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted and should be applied using a modified retrospective approach. We are in the process of evaluating the potential impacts of this new guidance on our consolidated financial statements and related disclosures.

In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting. The amendments in this updated guidance include changes to simplify the Codification for several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is permitted. We are in the process of evaluating the potential impacts of this new guidance on our consolidated financial statements.

There have been no changes in our significant accounting policies from those contained in our Annual Report on Form 10-K for the year ended December 31, 2015.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis describes results of operations and material changes in the financial condition of Owens & Minor, Inc. and its subsidiaries since December 31, 2015. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto, and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December 31, 2015.

Overview

Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading global healthcare services company that connects the world of medical products to the point of care. Recently, we have made certain changes to the leadership team, organizational structure, budgeting and financial reporting processes which drive changes to segment reporting. These changes align our operations into three distinct business units: Domestic, International and Clinical & Procedural Solutions (CPS). Domestic is our U.S. distribution, logistics and value-added services business, while International is our European distribution, logistics and value-added services business. CPS provides product-related solutions, including surgical and procedural kitting and sourcing. Furthermore, the basis for segment reporting shifts from the geography of the end customer to the business unit selling the product or providing the service. This includes intercompany transactions as well. Beginning with this quarter, we now report financial results using this three segment structure and have recast prior year segment results on the same basis. Segment financial information is provided in Note 13 of Notes to Consolidated Financial Statements included in this quarterly report.

Table of Contents

Financial highlights. The following table provides a reconciliation of reported operating earnings, net income and net income per diluted common share to non-GAAP measures used by management.



	Three Months Ended March 31,
(Dollars in thousands except per share data)	2016			2015
Operating earnings, as reported (GAAP)	$	44,970		$	40,975
Acquisition-related and exit and realignment charges	10,483			9,916
Operating earnings, adjusted (non-GAAP) (Adjusted Operated Earnings)	$	55,453		$	50,891
Adjusted Operating Earnings as a percent of revenue (non-GAAP)	2.26		%	2.13		%
Net income, as reported (GAAP)	$	24,135		$	18,940
Acquisition-related and exit and realignment charges, net of tax	7,129			8,592
Net income, adjusted (non-GAAP) (Adjusted Net Income)	$	31,264		$	27,532
Net income per diluted common share, as reported (GAAP)	$	0.39		$	0.30
Acquisition-related and exit and realignment charges, per diluted common share	0.11			0.14
Net income per diluted common share, adjusted (non-GAAP)(Adjusted EPS)	$	0.50		$	0.44

Adjusted EPS (non-GAAP) was $0.50 in the first quarter of 2016, an improvement of $0.06 when compared to prior year primarily as a result of improved operating earnings across all three segments. Domestic segment operating earnings of $41.7 million improved $3.6 million from the first quarter of 2015 as a result of revenue growth, expense control initiatives and higher income from manufacturer product price changes. The International segment improved in the first quarter of 2016 to operating income of $1.1 million, compared to an operating loss of $0.3 million in the same period of 2015, as a result of continued cost control and improved operational efficiency. CPS operating earnings of $13.3 million improved slightly compared to $13.2 million in 2015 primarily due to higher sales.

Use of Non-GAAP Measures

Adjusted operating earnings, adjusted net income and adjusted EPS are an alternative view of performance used by management, and we believe that investors' understanding of our performance is enhanced by disclosing these performance measures. In general, the measures exclude items and charges that (i) management does not believe reflect our core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results and in comparing our performance to that of our competitors. However, the non-GAAP financial measures used by us may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Acquisition-related charges, pre-tax, were $(0.4) million and $2.6 million in the first quarter of 2016 and 2015. The current quarter amount related to the gain on the sale of property acquired with the Medical Action acquisition. Charges in 2015 consisted primarily of costs to continue the integration of Medical Action and ArcRoyal which were acquired in the fourth quarter of 2014 including certain severance and contractual payments to the former owner and costs to transition information technology and other administrative functions.

Exit and realignment charges, pre-tax, were $10.9 million and $7.3 million in the first quarter of 2016 and 2015. Charges in the first quarter of 2016 primarily included costs associated with our voluntary employee separation program and other severance charges. Amounts in 2015 were associated with optimizing our operations and included costs for the consolidation of distribution and logistics centers and closure of offsite warehouses in the United States and Europe, as well as other costs associated with our strategic organizational realignment which included certain professional fees and costs to streamline administrative functions and processes in Europe.

These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes. Unless otherwise stated, our analysis hereinafter excludes acquisition-related and exit and realignment charges. More information about these charges is provided in Note 5 of Notes to Consolidated Financial Statements included in this quarterly report.

Table of Contents

Results of Operations

Net revenue.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2016			2015			$			%
Domestic	$	2,321,708		$	2,249,705		$	72,003		3.2	%
International	83,551			95,511			(11,960		)	(12.5	)%
CPS	141,353			129,645			11,708			9.0	%
Inter-segment	(90,819		)	(83,665		)	(7,154		)	8.6	%
Net revenue	$	2,455,793		$	2,391,196		$	64,597		2.7	%

Consolidated net revenue improved in the first quarter of 2016 as a result of the increase in our Domestic segment which resulted primarily from growth in larger healthcare provider customer accounts and an additional sales day in the first quarter of 2016 compared to 2015. Domestic segment growth rates are impacted by ongoing market trends including healthcare utilization rates. The decrease in the International segment was driven by unfavorable foreign currency translation impacts of $3.3 million and the exit of a U.K. customer contract in mid-2015. An increase in sales of custom procedure trays was the primary driver of the increase in CPS revenue compared to prior year.

Cost of goods sold.



	Three Months Ended March 31,				Change
(Dollars in thousands)	2016		2015		$		%
Cost of goods sold	$	2,159,157	$	2,093,595	$	65,562	3.1	%

Cost of goods sold includes the cost of the product (net of supplier incentives and cash discounts) and all costs incurred for shipments of products from manufacturers to our distribution centers for all customer arrangements where we are the primary obligor, bear risk of general and physical inventory loss and carry all credit risk associated with sales. These are sometimes referred to as distribution or buy/sell contracts. Cost of goods sold also includes direct and certain indirect labor, material and overhead costs associated with our kitting businesses. There is no cost of goods sold associated with our fee-for-service business. As a result of the increase in sales activity through our distribution and kitting businesses, cost of goods sold increased $65.6 million compared to the first quarter of 2015.

Gross margin.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2016			2015			$			%
Gross margin	$	296,636		$	297,601		$	(965	)	(0.3	)%
As a % of net revenue	12.08		%	12.45		%

Gross margin benefitted from the sales growth in the Domestic segment and higher income from manufacturer product price changes which were offset by the impacts of the U.K. customer exit in mid-2015 and $2.1 million in unfavorable impacts of foreign currency translation.

Operating expenses.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2016			2015			$			%
Distribution, selling & administrative expenses	$	242,725		$	249,694		$	(6,969	)	(2.8	)%
As a % of net revenue	9.88		%	10.44		%
Other operating income, net	$	(1,542	)	$	(2,984	)	$	1,442		(48.3	)%

Distribution, selling and administrative (DS&A) expenses include labor and warehousing costs associated with our distribution and logistics services and all costs associated with our fee-for-service arrangements. Shipping and handling costs are included in DS&A expenses and include costs to store, move, and prepare products for shipment, as well as costs to deliver

Table of Contents

products to customers. The costs to convert new customers to our information systems are included in DS&A and are generally incurred prior to the recognition of revenues from the new customers.

The decrease in DS&A expenses compared to prior year reflected the benefits of cost control initiatives, lower fuel costs and improved operational efficiency as well as favorable foreign currency translation impacts of $2.2 million.

The decrease in other operating income, net compared to 2015 was attributed primarily to changes in fair value of derivatives compared to prior year.

Interest expense, net.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2016			2015			$			%
Interest expense, net	$	6,790		$	6,880		$	(90	)	(1.3	)%
Effective interest rate	4.79		%	4.73		%

Interest expense in the first quarter of 2016 was consistent with prior year.

Income taxes.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2016			2015			$			%
Income tax provision	$	14,045		$	15,155		$	(1,110	)	(7.3	)%
Effective tax rate	36.8		%	44.4		%

The change in the effective tax rate compared to 2015, including income taxes on acquisition-related and exit and realignment charges, resulted from a higher percentage of the company's pretax income earned in lower tax rate jurisdictions compared to prior year and the deductibility of certain prior year acquisition-related charges for income tax purposes.

Table of Contents

Financial Condition, Liquidity and Capital Resources

Financial condition. We monitor operating working capital through days sales outstanding (DSO) and merchandise inventory turnover. We estimate a hypothetical increase (decrease) in DSO of one day would result in a decrease (increase) in our cash balances, an increase (decrease) in borrowings against our revolving credit facility, or a combination thereof of approximately $25 million.

The majority of our cash and cash equivalents are held in cash depository accounts with major banks in the United States and Europe or invested in high-quality, short-term liquid investments. Changes in our working capital can vary in the normal course of business based upon the timing of inventory purchases, collection of accounts receivable, and payment to suppliers.



	March 31, 2016		December 31, 2015		Change
(Dollars in thousands)	March 31, 2016		December 31, 2015		$			%
Cash and cash equivalents	$	190,323	$	161,020	$	29,303		18.2	%
Accounts and notes receivable, net of allowances	$	615,750	$	587,935	$	27,815		4.7	%
Consolidated DSO ⁽¹⁾	21.8		21.0
Merchandise inventories	$	925,714	$	940,775	$	(15,061	)	(1.6	)%
Consolidated inventory turnover ⁽²⁾	9.3		9.4
Accounts payable	$	758,585	$	710,609	$	47,976		6.8	%

(1) Based on period end accounts receivable and net revenue for the quarter

(2) Based on average annual inventory and costs of goods sold for the quarter ended March 31, 2016 and year ended December 31, 2015

Liquidity and capital expenditures. The following table summarizes our consolidated statements of cash flows for the three months ended March 31, 2016 and 2015:



(Dollars in thousands)	2016			2015
Net cash provided by (used for):
Operating activities	$	44,895		$	168,703
Investing activities	(2,461		)	(11,516		)
Financing activities	(16,066		)	(50,414		)
Effect of exchange rate changes	2,935			(4,489		)
Increase in cash and cash equivalents	$	29,303		$	102,284

Cash provided by operating activities was $44.9 million in the first three months of 2016, compared to $168.7 million in the same period of 2015. The decrease in cash from operating activities for the first three months of 2016 compared to the same period in 2015 was primarily due to routine changes in working capital, including timing of payments to vendors in the prior year. Depreciation and amortization in the first quarter of 2015 included $3.0 million in accelerated amortization related to an information system that was replaced in the International segment.

Cash used for investing activities was $2.5 million in the first three months of 2016, compared to $11.5 million in the same period of 2015. Investing activities in 2016 and 2015 relate to capital expenditures for our strategic and operational efficiency initiatives, particularly initiatives relating to information technology enhancements and optimizing our distribution network. Cash used for investing activities in 2016 was partially offset by $4.6 million in proceeds from the sale of property.

Cash used for financing activities in the first three months of 2016 was $16.1 million, compared to $50.4 million used in the same period of 2015. During the first three months of 2016, we paid dividends of $16.0 million (compared to $15.9 million in the same period of 2015) and repurchased $5.6 million in common stock. Financing activities in the first quarter of 2015 included a $33.7 million repayment under our revolving credit facility.

Capital resources. Our sources of liquidity include cash and cash equivalents and a revolving credit facility. On September 17, 2014, we amended our existing Credit Agreement with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A., Bank of America, N.A. and a syndicate of financial institutions (the Amended Credit Agreement) increasing our borrowing capacity from $350 million to $450 million and extending the term through 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between

Table of Contents

12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. We may utilize the revolving credit facility for long-term strategic growth, capital expenditures, working capital and general corporate purposes. If we were unable to access the revolving credit facility, it could impact our ability to fund these needs. Based on our leverage ratio at March 31, 2016, the interest rate under the credit facility is LIBOR plus 1.375%.

At March 31, 2016 , we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of March 31, 2016 and December 31, 2015 which supports our facilities leased in Europe.

We have $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”). The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal amount with an effective yield of 4.422%. Interest on the 2021 Notes and 2024 Notes is payable semiannually in arrears, which commenced on March 15, 2015 and December 15, 2014, respectively. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points.

In the first quarter of 2016, we paid cash dividends on our outstanding common stock at the rate of $0.255 per share, which represents a 1.0% increase over the rate of $0.2525 per share paid in the first quarter of 2015. We anticipate continuing to pay quarterly cash dividends in the future. However, the payment of future dividends remains within the discretion of the Board of Directors and will depend upon our results of operations, financial condition, capital requirements and other factors.

In February 2014, the Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders, and may be suspended or discontinued at any time. During the first quarter of 2016, we repurchased 0.2 million shares at $5.6 million. At March 31, 2016, the remaining amount authorized for repurchase under this program was $64.4 million.

We earn a portion of our operating earnings in foreign jurisdictions outside the U.S., which we consider to be indefinitely reinvested. Accordingly, no U.S. federal and state income taxes and withholding taxes have been provided on these earnings. Our cash, cash-equivalents, short-term investments, and marketable securities held by our foreign subsidiaries totaled $46.5 million and $46.0 million as of March 31, 2016 and December 31, 2015. We do not intend, nor do we foresee a need, to repatriate these funds or other assets held outside the U.S. In the future, should we require more capital to fund discretionary activities in the U.S. than is generated by our U.S.-based operations and is available through our borrowings, we could elect to repatriate cash or other assets from foreign jurisdictions that have previously been considered to be indefinitely reinvested.

We believe available financing sources, including cash generated by operating activities and borrowings under the Amended Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in economic conditions may impact (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us or (iii) our cost of borrowing.

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see our Annual Report on Form 10-K for the year ended December 31, 2015 and Note 15 in the Notes to Consolidated Financial Statements, included in this Quarterly Report on Form 10-Q for the quarterly period ended on March 31, 2016.

Forward-looking Statements

Certain statements in this discussion constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of our knowledge of our business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks, including, but not limited to:


•	competitive pressures in the marketplace, including intense pricing pressure;


•	our ability to retain existing and attract new customers in a market characterized by significant customer consolidation and intense cost-containment initiatives;

Table of Contents


•	our dependence on sales to certain customers or the loss or material reduction in purchases by key customers;


•	our dependence on distribution of product of certain suppliers;


•	our ability to successfully identify, manage or integrate acquisitions;


•	our ability to successfully manage our international operations, including risks associated with changes in international trade regulations, foreign currency volatility, changes in regulatory conditions, deteriorating economic conditions, adverse tax consequences, and other risks of operating in international markets;


•	uncertainties related to and our ability to adapt to changes in government regulations, including healthcare laws and regulations (including the Affordable Care Act);


•	risks arising from possible violations of legal, regulatory or licensing requirements of the markets in which we operate;


•	uncertainties related to general economic, regulatory and business conditions;


•	our ability to successfully implement our strategic initiatives;


•	the availability of and modifications to existing supplier funding programs and our ability to meet the terms to qualify for certain of these programs;


•	our ability to adapt to changes in product pricing and other terms of purchase by suppliers of product;


•	the ability of customers and suppliers to meet financial commitments due to us;


•	changes in manufacturer preferences between direct sales and wholesale distribution;


•	changing trends in customer profiles and ordering patterns and our ability to meet customer demand for additional value-added services;


•	our ability to manage operating expenses and improve operational efficiencies in response to changing customer profiles;


•	our ability to meet performance targets specified by customer contracts under contractual commitments;


•	availability of and our ability to access special inventory buying opportunities;


•	the ability of business partners and financial institutions to perform their contractual responsibilities;


•	the effect of price volatility in the commodities markets, including fuel price fluctuations, on our operating costs and supplier product prices;


•	our ability to continue to obtain financing at reasonable rates and to manage financing costs and interest rate risk;


•	the risk that information systems are interrupted or damaged or fail for any extended period of time, that new information systems are not successfully implemented or integrated, or that there is a data security breach in our information systems;


•	the risk that a decline in business volume or profitability could result in an impairment of goodwill or other long-lived assets;


•	our ability to timely or adequately respond to technological advances in the medical supply industry;


•	the costs associated with and outcome of outstanding and any future litigation, including product and professional liability claims;


•	adverse changes in U.S. and foreign tax laws and the outcome of outstanding tax contingencies and legislative and tax proposals; and


•	other factors described in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2015.

We undertake no obligation to update or revise any forward-looking statements, except as required by applicable law.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in interest rates related to our revolving credit facility. We had no outstanding borrowings and approximately $5.0 million in letters of credit under the revolving credit facility at March 31, 2016. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $0.1 million per year for every $10 million of outstanding borrowings under the revolving credit facility.

Due to the nature and pricing of our Domestic segment distribution services, we are exposed to potential volatility in fuel prices. Our strategies for helping to mitigate our exposure to changing domestic fuel prices has included entering into leases for trucks with improved fuel efficiency. We benchmark our domestic diesel fuel purchase prices against the U.S. Weekly Retail On-Highway Diesel Prices (benchmark) as quoted by the U.S. Energy Information Administration. The benchmark averaged $2.07 per gallon in the first three months of 2016, a decrease from $2.92 per gallon in the first three months of 2015. Based on our fuel consumption in the first three months of 2016, we estimate that every 10 cents per gallon increase in the benchmark would reduce our Domestic segment operating earnings by approximately $0.3 million on an annualized basis.

In the normal course of business, we are exposed to foreign currency translation and transaction risks. Our business transactions outside of the United States are primarily denominated in the Euro and British Pound. We may use foreign currency forwards, swaps and options, where possible, to manage our risk related to certain foreign currency fluctuations. However, we believe that our foreign currency transaction risks are low since our revenues and expenses are typically denominated in the same currency.

Item 4. Controls and Procedures

We carried out an evaluation, with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2016. There has been no change in our internal control over financial reporting during the quarter ended March 31, 2016, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

Certain legal proceedings pending against us are described in our Annual Report on Form 10-K for the year ended December 31, 2015. Through March 31, 2016, there have been no material developments in any legal proceedings reported in such Annual Report.

Item 1A. Risk Factors

Certain risk factors that we believe could affect our business and prospects are described in our Annual Report on Form 10-K for the year ended December 31, 2015. Through March 31, 2016, there have been no material changes in the risk factors described in such Annual Report.

Table of Contents

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

In February 2014, our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders. The program may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. For the three months ended March 31, 2016, we repurchased in open-market transactions and retired 0.2 million shares of our common stock for an aggregate of $5.6 million, or an average price per share of $34.61. The following table summarizes share repurchase activity by month during the three months ended March 31, 2016.



Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of a publicly announced program	Maximum dollar value of shares that may yet be purchased under the program
January 2016	111,680	$	33.89	111,680	$	66,725,109
February 2016	34,918	$	34.80	34,918	$	65,000,070
March 2016	16,099	$	39.16	16,099	$	64,369,676
Total	162,697			162,697

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		Owens & Minor, Inc.
		(Registrant)

Date:	May 4, 2016	/s/ Paul C. Phipps
		Paul C. Phipps
		President & Chief Executive Officer

Date:	May 4, 2016	/s/ Richard A. Meier
		Richard A. Meier
		Executive Vice President, Chief Financial Officer & President, International

Table of Contents

Item 6. Exhibits


(a)	Exhibits




10.1		Form of Restricted Stock Unit Agreement under the Company’s 2015 Stock Incentive Plan (“2015 Plan”)

10.2		Form of Restricted Stock Agreement under the 2015 Plan

10.3		Form of Director Restricted Stock Agreement under the 2015 Plan

10.4		Form of 2016 Performance Share Award Agreement

10.5		Form of 2016 Executive Incentive Program

10.6		Amendment effective March 1, 2016 of the Company’s Supplemental Executive Retirement Plan (“SERP”)

10.7		Amendment effective March 1, 2016 of Exhibit II of the Company’s SERP

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document